Isabel Burghardt
Zurich, ZH 8091, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype.
Journal: Journal of neuropathology and experimental neurology
Published: February 22, 2022
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.
Journal: Neuro-oncology practice
Published: April 26, 2021
Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma.
Journal: Molecular therapy oncolytics
Published: August 19, 2020
A tumor-promoting role for soluble TβRIII in glioblastoma.
Journal: Molecular and cellular biochemistry
Published: June 24, 2020
Endoglin and TGF-β signaling in glioblastoma.
Journal: Cell and tissue research
Published: June 17, 2020
Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.
Journal: EMBO molecular medicine
Published: May 10, 2019
Corrigendum: Computer-assisted quantification of motile and invasive capabilities of cancer cells.
Journal: Scientific reports
Published: July 03, 2018
TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.
Journal: Journal of cell science
Published: August 15, 2017
Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-β and Furin in Glioma-Initiating Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 18, 2016
Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma.
Journal: Molecular cancer therapeutics
Published: July 14, 2016
Last Updated: 09/26/2026